Skip to main content
Semler Scientific, Inc. logo

Semler Scientific, Inc. — Investor Relations & Filings

Ticker · SMLR ISIN · US81684M1045 LEI · 549300ZHL16S29QTW485 US Professional, scientific and technical activities
Open in API
Filings indexed 864 across all filing types
Latest filing 2014-02-20 Director's Dealing
Country US United States of America
Listing US SMLR

About Semler Scientific, Inc.

https://www.semlerscientific.com/

Semler Scientific, Inc. is a company that develops, manufactures, and markets technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. Its primary focus is on products and services that support the early detection and treatment of chronic diseases. The company's flagship product is a patented, FDA-cleared system that provides a rapid, point-of-care test to aid in the diagnosis of peripheral artery disease (PAD). In addition to its healthcare technology operations, the company has adopted a corporate strategy to acquire and hold bitcoin as its primary treasury reserve asset.

Recent filings

Filing Released Lang Actions
OWNERSHIP DOCUMENT
Director's Dealing
2014-02-20 English
OWNERSHIP DOCUMENT
Director's Dealing
2014-02-20 English
ISSUER FREE WRITING PROSPECTUS
Capital/Financing Update Classification · 95% confidence The document is an Issuer Free Writing Prospectus (FWP) related to an initial public offering (IPO) of common stock by Semler Scientific, Inc. It references a preliminary prospectus and a registration statement filed with the SEC. The content focuses on details about potential purchases by affiliates, ownership percentages post-offering, and control implications. This type of document is a prospectus supplement or offering communication, which is a capital markets disclosure related to fundraising activities. It is not a financial report, earnings release, or management discussion. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2014-02-20 English
Capital/Financing Update 2014
Capital/Financing Update Classification · 95% confidence The document is a letter from Semler Scientific, Inc. to the SEC requesting acceleration of the effective date of a Registration Statement on Form S-1. It references the Securities Act of 1933 and the registration process for securities offerings. The document is a formal request related to the registration and effectiveness of a securities offering, not a financial report, earnings release, or other types of filings. It is specifically about the registration statement's effectiveness timing, which falls under capital raising activities. Therefore, the document is best classified as a Capital/Financing Update (CAP). The document length is short and it is not a report itself but a regulatory filing related to capital raising.
2014-02-18 English
ISSUER FREE WRITING PROSPECTUS
Capital/Financing Update Classification · 95% confidence The document is titled 'Issuer Free Writing Prospectus' and is filed pursuant to Rule 433, which is a SEC rule related to free writing prospectuses used in securities offerings. The content includes forward-looking statements, details about an initial public offering (IPO), use of proceeds, management team, product description, market opportunity, and business model. It is a detailed presentation aimed at investors about the company's offering and business, typical of a free writing prospectus used in capital raising activities. There is no indication that this is a full annual or quarterly report, audit report, earnings release, or other regulatory filing. The document is not a simple announcement or notice but a detailed investor communication related to financing. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2014-02-18 English
AMENDMENT NO. 5 TO FORM S-1
Capital/Financing Update Classification · 100% confidence The document is an Amendment No. 5 to Form S-1 filed with the SEC, which is a registration statement under the Securities Act of 1933. It is related to an initial public offering (IPO) of common stock by Semler Scientific, Inc. The text includes detailed information about the offering, the company's business, risk factors, management discussion, and financial data. Form S-1 and its amendments are filings related to capital raising and securities registration, not annual or quarterly reports, earnings releases, or other types of filings. Therefore, this document is best classified as a Capital/Financing Update (CAP), which covers company fundraising and financing activities.
2014-02-18 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.